OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
COVID-19 mRNA Vaccine in Patients With Lymphoid Malignancy or Anti-CD20 Antibody Therapy: A Systematic Review and Meta-Analysis
Yusuke Ito, Akira Honda, Mineo Kurokawa
Clinical Lymphoma Myeloma & Leukemia (2022) Vol. 22, Iss. 8, pp. e691-e707
Open Access | Times Cited: 12
Yusuke Ito, Akira Honda, Mineo Kurokawa
Clinical Lymphoma Myeloma & Leukemia (2022) Vol. 22, Iss. 8, pp. e691-e707
Open Access | Times Cited: 12
Showing 12 citing articles:
Immunocompromised Host Pneumonia: Definitions and Diagnostic Criteria: An Official American Thoracic Society Workshop Report
Guang-Shing Cheng, Kristina Crothers, Stefano Aliberti, et al.
Annals of the American Thoracic Society (2023) Vol. 20, Iss. 3, pp. 341-353
Open Access | Times Cited: 34
Guang-Shing Cheng, Kristina Crothers, Stefano Aliberti, et al.
Annals of the American Thoracic Society (2023) Vol. 20, Iss. 3, pp. 341-353
Open Access | Times Cited: 34
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, et al.
Leukemia (2023) Vol. 37, Iss. 6, pp. 1175-1185
Open Access | Times Cited: 33
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, et al.
Leukemia (2023) Vol. 37, Iss. 6, pp. 1175-1185
Open Access | Times Cited: 33
Second Booster BNT162b2 Restores SARS-CoV-2 Humoral Response in Patients With Multiple Myeloma, Excluding Those Under Anti-BCMA Therapy
Ioannis Ntanasis‐Stathopoulos, Vangelis Karalis, Maria Gavriatopoulou, et al.
HemaSphere (2022) Vol. 6, Iss. 8, pp. e764-e764
Open Access | Times Cited: 25
Ioannis Ntanasis‐Stathopoulos, Vangelis Karalis, Maria Gavriatopoulou, et al.
HemaSphere (2022) Vol. 6, Iss. 8, pp. e764-e764
Open Access | Times Cited: 25
Efficacy of COVID-19 Booster Vaccines in Patients with Hematologic Malignancies: Experiences in a Real-World Scenario
Carolin Krekeler, Lea Reitnauer, Ulrike Bacher, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5512-5512
Open Access | Times Cited: 18
Carolin Krekeler, Lea Reitnauer, Ulrike Bacher, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5512-5512
Open Access | Times Cited: 18
Management of vaccinations in patients with non‐Hodgkin lymphoma
Michele Merli, Andrea Costantini, Silvio Tafuri, et al.
British Journal of Haematology (2024) Vol. 204, Iss. 5, pp. 1617-1634
Open Access | Times Cited: 2
Michele Merli, Andrea Costantini, Silvio Tafuri, et al.
British Journal of Haematology (2024) Vol. 204, Iss. 5, pp. 1617-1634
Open Access | Times Cited: 2
Heterologous SARS-CoV-2 booster vaccine for individuals with hematological malignancies after a primary SARS-CoV-2 mRNA vaccine series
Amy C Sherman, Simon D. van Haren, Ella Borberg, et al.
Vaccine (2024) Vol. 42, Iss. 22, pp. 126054-126054
Closed Access | Times Cited: 2
Amy C Sherman, Simon D. van Haren, Ella Borberg, et al.
Vaccine (2024) Vol. 42, Iss. 22, pp. 126054-126054
Closed Access | Times Cited: 2
Delphi Panel Consensus Statement Generation: COVID-19 Vaccination Recommendations for Immunocompromised Populations in the European Union
Jaya Paranilam, Francesco Arcioni, Antonio Franco, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 11, pp. 2227-2253
Open Access | Times Cited: 1
Jaya Paranilam, Francesco Arcioni, Antonio Franco, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 11, pp. 2227-2253
Open Access | Times Cited: 1
COVID-19 vaccine response and safety in patients with cancer: An overview of systematic reviews
Hong Sun, Fengjiao Bu, Ling Li, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 6
Hong Sun, Fengjiao Bu, Ling Li, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 6
COVID-19 Vaccination Recommendations for Immunocompromised Patient Populations: Delphi Panel and Consensus Statement Generation in the United States
Kira Zhi Hua Lai, Stuart Greenstein, Rajesh Govindasamy, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 11, pp. 2255-2283
Open Access
Kira Zhi Hua Lai, Stuart Greenstein, Rajesh Govindasamy, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 11, pp. 2255-2283
Open Access
SARS-CoV-2-Specific T Lymphocytes Analysis in mRNA-Vaccinated Patients with B-Cell Lymphoid Malignancies on Active Treatment
Patricia García Ramírez, Marta Callejas Charavía, Raquel Oliva Martin, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 961-961
Open Access
Patricia García Ramírez, Marta Callejas Charavía, Raquel Oliva Martin, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 961-961
Open Access
Humoral and cellular BNT162b2 mRNA-based booster vaccine-induced immunity in patients with multiple myeloma and persistence of neutralising antibodies: results of a prospective single-centre cohort study
Tobias Silzle, Christian R. Kahlert, Werner C. Albrich, et al.
Schweizerische medizinische Wochenschrift (2023) Vol. 153, Iss. 6, pp. 40090-40090
Open Access
Tobias Silzle, Christian R. Kahlert, Werner C. Albrich, et al.
Schweizerische medizinische Wochenschrift (2023) Vol. 153, Iss. 6, pp. 40090-40090
Open Access
Reply to Çınar et al. Comment on “Zamfir et al. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. Medicina 2022, 58, 874”
Ana Căruntu, Constantin Căruntu, Cristian Scheau
Medicina (2022) Vol. 58, Iss. 11, pp. 1576-1576
Open Access
Ana Căruntu, Constantin Căruntu, Cristian Scheau
Medicina (2022) Vol. 58, Iss. 11, pp. 1576-1576
Open Access
